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ABSTRACT
P2RX7, a mediator of IL-1 and IL-18 processing and re-
lease, is a ligand-gated cation channel that is ex-
pressed by macrophages. In experimental Crgn, P2RX7
deficiency attenuates renal injury, but the underlying
mechanism is unknown. Here, we show that P2RX7 lev-
els and the expression of several genes belonging to
the Nlrp3-inflammasome pathway are up-regulated in
the macrophages of the WKY rat, a strain uniquely sus-
ceptible to macrophage-dependent NTN. Importantly,
following P2RX7 activation, WKY BMDMs produce
markedly increased levels of active caspase-1, IL-1,
and IL-18 when compared with the NTN-resistant LEW
rat BMDMs. P2RX7 and active IL-1, IL-18, and
caspase-1 protein levels were markedly increased in
the WKY nephritic glomeruli 4 days following induction
of NTN, and the use of a P2RX7 antagonist reduced the
levels of secreted active IL-1. Interestingly, the post-
translational control of P2RX7-mediated inflammasome
activation is under the genetic regulation of two previ-
ously identified Crgn quantitative trait loci in the BMDMs
and nephritic glomeruli of the WKY rat. In conclusion,
we propose a novel mechanism, whereby genetically
determined P2RX7 levels in macrophages regulate
Nlrp3-inflammasome activation and susceptibility to
Crgn. J. Leukoc. Biol. 93: 127–134; 2013.
Introduction
Crgn is the most severe form of glomerular inflammation and
presents clinically as rapidly progressive glomerulonephritis.
Crgn is characterized by disruption of the GBM, leading to the
infiltration and proliferation of inflammatory cells, such as
macrophages in Bowman’s space [1, 2]. Macrophages are im-
portant immune effector cells and are the predominant im-
mune cell found within crescentic glomeruli playing pivotal
roles. Numerous studies using different models of experimen-
tal Crgn have established a role for both macrophage activa-
tion and numbers in the progression of Crgn [3–5].
The rat model of NTN in the WKY strain is dependent on
macrophage infiltration and activation in response to glomeru-
lar deposition of immunoglobulin. In this model, glomerular
macrophage infiltration peaks at Day 4 following a single injec-
tion of rabbit anti-GBM antiserum [6]. The WKY NTN model
is a highly reproducible model, which is very similar in its his-
tological features to human Crgn. It is particularly useful for
studying the role of cell-mediated innate immunity against the
planted IgG in the GBM and specifically, for studying the role
of macrophages in crescent formation. The WKY NTN model
has been used to identify genetic loci that promote macro-
phage-dependent susceptibility to Crgn. Previous genome-wide
linkage analysis carried out in the NTN-susceptible WKY and
NTN-resistant LEW strains identified seven Crgn QTL [7]. The
most significant are QTL controlling crescent formation and
proteinuria mapped to chromosome 13 (Crgn1) and chromo-
some 16 (Crgn2) [7]. These loci showed highly significant
LOD scores (LOD8), and introgression of LEW Crgn1 or
LEW Crgn2 into the WKY genetic background, generated by
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single congenic animals, resulted in a reduction of glomerular
crescent formation of 18% and 8%, respectively [8]. Positional
cloning studies led to the identification of genes controlling
FcR-mediated macrophage activation [7, 9, 10]. Further ge-
netic studies using congenic rat strains suggested that the poly-
genic regulation of NTN susceptibility in the WKY rat is under
the control of macrophage activation rather than infiltration
[8]. In addition to FcR-mediated macrophage activation, WKY
and LEW BMDMs show differences in their superoxide anion
production and LPS-stimulated NOS2 expression. Macrophage
activation is also partly determined by the cell transcriptome,
and we have reported that in addition to the observed differ-
ences in macrophage function, there is a major transcriptome
difference (800 differentially expressed transcripts; false dis-
covery rate 5%) between the BMDMs of WKY and LEW rats
[11]. In recent years, there have been numerous studies focus-
ing on altering macrophage function in the pathophysiology
of NTN. We have shown that blockade of proinflammatory
(M1 phenotype) or promoting the anti-inflammatory (M2)
phenotype of glomerular macrophages ameliorates disease in
the WKY NTN model [12–15].
ATP is an important inflammatory mediator in macrophages
[16]. P2RX7, a ligand-gated ion channel, was first cloned from
the rat brain [17], and its stimulation in the presence of high
ATP concentration leads to release of inflammatory mediators,
such as IL-1 [18, 19] and IL-18 [19]. P2RX7 protein is ex-
pressed in normal kidney, and although glomerular expression
of the molecule is scarce in normal kidney, it is up-regulated
following injury, including acute and chronic inflammatory
conditions [20, 21]. Notably, P2RX7 expression reaches its
peak at Day 4 (which coincides with maximal glomerular mac-
rophage infiltration) following injection of nephrotoxic serum
in the glomeruli of WKY rats [22]. The same study also re-
ported up-regulation of P2RX7 in human lupus-related glo-
merulonephritis [22]. The P2RX7-mediated release of IL-1
and IL-18 is a two-step phenomenon regulated at transcrip-
tional and post-translational maturation levels. These cytokines
are produced as proforms and require the activation of
caspase-1, also known as the IL-1-converting enzyme, for mat-
uration and secretion. The inflammasomes are molecular plat-
forms that can trigger the activation of inflammatory caspases,
such as caspase-1 and processing of pro-IL-1 and pro-IL-18.
Since their discovery 10 years ago [23], Nlrp1, Nlrp3, and
Nlrc4 and the adapter protein ASC have been identified as
critical components of the inflammasome by linking microbial
and endogenous signals to caspase-1 activation and subsequent
release of IL-1 and IL-18 [24]. The activation of the NLRP3
inflammasome induced by stimulation of the P2X7R requires
two signals. The first signal is the stimulation with endogenous
cytokines (i.e., TNF-) or microbial ligands, such as LPS, and
is necessary to induce the up-regulation of NLRP3, which is
otherwise expressed at low levels in resting conditions [25,
26]. The second signal that leads to fully active NLRP3 inflam-
masome is characterized by the engagement of P2RX7 by high
concentrations (5 mM) of ATP [27], which induce complete
collapse of normal ionic gradients, including the release of
intracellular potassium [19, 28]. This P2RX7-stimulated IL-
and IL-18 release is dependent on Nlrp3-inflammasome activa-
tion, as mice depleted of ASC or Nlrp3 are unable to process
and secrete mature IL-1 in response to ATP [29, 30].
By using two distinct models of experimental Crgn, we have
shown previously that P2RX7 has a proinflammatory role in
the progression of renal injury. We reported that P2RX7/
mice had less severe glomerular thrombosis, proteinuria, and
macrophage infiltration when compared with WT controls fol-
lowing induction of ANTN [31]. In the WKY rat model of
NTN, which unlike ANTN does not require preimmunization,
early treatment of rats with a P2RX7 blocker (A-438079) re-
sulted in significantly reduced proteinuria and macrophage
infiltration when compared with vehicle-treated controls [31].
In the present study, we hypothesized that P2RX7 is a ge-
netic determinant of macrophage activation and that its cellu-
lar levels regulate the processing of active to IL-1 and IL-18
in the inflamed glomerulus through the activation of Nlrp3
inflammasome. We studied P2RX7-mediated Nlrp3-inflam-
masome activation in the BMDMs and nephritic glomeruli of
three strains of rat: the NTN-susceptible WKY rat, the NTN-
resistant LEW rat, and the double-congenic WKY.LCrgn1,2 rat.
In the latter strain, the two major QTL identified by genome-
wide linkage analysis (Crgn1 and Crgn2) were introgressed
from the resistant LEW rats into the genetic background of
the WKY rat. We have shown previously that these double-con-
genic rats had 40% reduction in glomerular crescents in NTN
when compared with parental WKY rats [8]. Based on our re-
sults, we propose a novel mechanism in the genetic control of




P2RX7/, which was originally generated by Pfizer (Groton, CT, USA),
was purchased from The Jackson Laboratory (Bar Harbor, ME, USA). WKY
(WKY/NCrl) and LEW (LEW/Crl) rats were purchased from Charles River
Laboratories International (Wilmington, MA, USA). The generation of the
double-congenic line WKY.LCrgn1,2 from single-congenic F1 animals was
described previously [8]. All procedures were performed in accordance
with the United Kingdom Animals (Scientific Procedures) Act.
BMDM culture and stimulation
Murine and rat BMDMs were isolated from adult femurs and cultured for 5
days in the presence of L929 medium as described previously [8]. These
cells were characterized as macrophages by immunohistochemistry for
CD68, and 99% of the cells were CD68. On Day 6 of differentiation,
the medium was aspirated, and macrophages were primed for 5 h, unless
specified otherwise, with 1 g/mL LPS from Escherichia coli (Sigma, UK) in
serum-free DMEM, supplemented with 100 IU penicillin and 100 g/mL
streptomycin. Following the LPS priming, the medium was aspirated, cells
were washed with HBSS, and fresh, serum-free medium containing ATP at
a concentration of 5 mM was added. In some experiments, 10 g/ml Nige-
ricin (Sigma) was added. After 30 min of ATP (or Nigericin) stimulation,
culture medium and cell layers were collected by scraping. In some condi-
tions, the P2RX7 inhibitor AZ10606120 dihydrochloride (Tocris Bioscience,
Bristol, UK) was added before stimulating the cells with ATP.
NTN, isolation of rat nephritic glomeruli, and
immunostaining
NTN was induced in male WKY, LEW, and WKY.LCrgn1,2 rats by i.v. injec-
tion of 0.1 ml nephrotoxic serum, as described previously [9]. On Day 4
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after induction of NTN, rats were killed under isoflurane anesthesia and
kidneys placed immediately in cold PBS. Glomeruli were isolated by se-
quential sieving using stainless-steel meshes of 250, 150, and 75 m in cold
PBS, followed by centrifugation at 1500 rpm for 5 min. The glomerular
pellet was then suspended in DMEM, supplemented with penicillin and
streptomycin. A number of 1  104 glomeruli were seeded into each well
of a six-well plate using 1 ml DMEM/well. After 48 h of incubation at 37°C,
supernatants and glomerular layers were collected and stored at 20°C for
further analysis. In some conditions, the nephritic glomeruli from the WKY
rats were washed following 24 h of culture, and the remaining macro-
phages were cultured for an additional 24 h. For ED-1 (AbD Serotec, Ox-
ford, UK) and Nlrp3 (Abcam, Cambridge, UK) immunostaining, formalin-
fixed, paraffin-embedded rat tissues were microwaved in sodium citrate buf-
fer for antigen retrieval. Following consecutive blocking steps (peroxide
block for 15 min, 10% goat serum block for 15 min, followed by a 10%
milk block for 15 min), sections were incubated with the primary antibody
ED-1 (1:500) or NALP-3 (1:100) and the slides left for 1 h at room temper-
ature. The slides were then washed and incubated in the polymer-HRP
(Dako mouse EnVision kit, Dako, Denmark) for 30 min at room tempera-
ture. Staining was visualized using DAB (Dako EnVision kit) and sections
counterstained with hematoxylin, dehydrated, and mounted with cover
slips.
Western blotting and ELISA
The cell monolayer or glomerular preparation was washed once with cold
1 PBS and suspended immediately in lysis buffer. Lysates were clarified by
centrifugation (13,500 g, 20 min), and the protein concentration in the
supernatants was measured using the BCA protein assay kit (Pierce, UK),
following the manufacturer’s instructions. To analyze secreted proteins,
cells were scraped, and cell layers and supernatant s were collected and
filtered using Amicon ultra centrifugal filters (10 kDa cutoff; Millipore,
UK) for protein purification and concentration. The concentrated samples
were diluted with 5 sample buffer, boiled for 10 min, resolved by SDS-
PAGE, and transferred to an Immobilon-P transfer membrane (Millipore).
The primary antibodies used were as follows: rabbit polyclonal anti IL-1
(New England BioLabs, UK), rabbit polyclonal anti IL-18 (Santa Cruz Bio-
technology, Santa Cruz, CA, USA), rabbit polyclonal anti caspase-1 (Santa
Cruz Biotechnology), and rabbit polyclonal anti-P2X7 (Alomone Labs, Is-
rael). IL-1 levels were quantified by sandwich ELISA (R&D Systems,
Abingdon, UK), according to the manufacturer’s instructions.
RNA extraction and qRT-PCR
Total RNA was extracted from BMDMs using the Trizol method. Total
RNA concentration was determined using a NanoDrop spectrophotometer
(Labtech International, Ringmer, UK). Real-time RT-PCR was performed
on an ABI 7500 sequence detection system (Applied Biosystems, War-
rington, UK) using SYBR Green (Stratagene, Cambridge, UK). A total of
100 ng total RNA was used for qRT-PCR, and all samples were amplified in
triplicate using transcript-specific primers. The primers used in this study
were as follows: P2RX7, forward 5=TCGGTTTGGCCACCGTGTGT-3= and
reverse 5= CATTCACTGCACAGGGCTCGCA-3=; Il1RN, forward
5=CTTTTCTGTGTGATGCCCCT-3= and reverse 5=GTGAAGATGGT-
GTTTGGGCT-3=; Il18, forward 5=ACCGCAGTAATACGGAGCAT-3=and re-
verse, 5=TAGGGTCACAGCCAGTCCTC-3=; IL18bp forward 5=ATGAGA-
CACTGTGGCTGTGC -3= and reverse 5=ACTGCTGGAGACCAGGAAGA-3=;
Nlrp3, forward 5=GCTGCTCAGCTCTGACCTCT-3= and reverse 5=AGGT-
GAGGCTGCAGTTGTCT-3=; ASC, forward 5=GCAATGTGCTGACT-
GAAGGA-3= and reverse 5=TGTTCCAGGTCTGTCACCAA-3=; Casp1, for-
ward 5=GGAGGGAATATGTGGGATCA-3= and reverse Casp1 5=
CCCTCTTCGGAGTTCCCTAC-3=. Results were exported to 7500 Fast Sys-
tem SDS software and analyzed as described previously [8].
Statistical analysis
Data were expressed as mean  sem. Statistical difference was assessed by a
single-factor variance (ANOVA), followed by Bonferroni multiple compari-
sons post-test; P  0.05 was considered statistically significant.
RESULTS AND DISCUSSION
P2RX7-Nlrp3-inflammasome gene expression in WKY,
LEW, and WKY.LCrgn1,2 BMDMs
In our previous microarray analysis of WKY and LEW BMDMs,
we identified P2RX7, IL-1RN, and IL-18 as markedly overex-
pressed transcripts in the WKY macrophages [11]. Based on
these results, we hypothesized that the P2RX7-Nlrp3-inflam-
masome pathway genes may also be expressed differentially
between the macrophages of the two strains of rat. In addition
to P2RX7, IL-1RN and IL-18, the basal expression levels of
caspase-1, IL-18BP, and LPS-stimulated Pycard (ASC) expres-
sion was found to be up-regulated significantly in WKY
BMDMs (Fig. 1A and B). The transcriptional regulation of all
of these transcripts was not under the control of Crgn1 and
Crgn2, as the congenic WKY.LCrgn1,2 BMDMs showed similar
expression levels to the parental WKY BMDMs (Fig. 1A). The
P2RX7 protein levels were also increased in basal and LPS-
stimulated WKY BMDMs when compared with LEW BMDMs
(Fig. 1C). The WKY and LEW strains also show sequence vari-
ants within the P2RX7 gene (Supplemental Fig. 1). However
P2RX7 protein levels are under partial genetic control of
Crgn1 and Crgn2, as the LPS-stimulated WKY.LCrgn1,2
BMDMs showed reduced levels of P2RX7 protein levels (Fig.
1C). Furthermore, we confirmed that P2RX7 is essential for
ATP-induced Nlrp3-inflammasome activation, and its blockade
leads to reduced active IL-1 in WKY BMDMs and nephritic
glomeruli (Supplemental Fig. 2).
P2RX7-Nlrp3-inflammasome-mediated IL-1 and IL-18
release in WKY, LEW, and WKY.LCrgn1,2 BMDMs
To activate the P2RX7-Nlrp3-inflammasome pathway, BMDMs
from WKY, LEW, and WKY.LCrgn1,2 rats were first primed
with LPS (1 g/ml, 3 h). ATP (5 mM) was then added to the
cells for 30 min. The active and pro forms of IL-1, IL-18, and
caspase-1 were assessed in the cell lysates and supernatants of
BMDMs from the different rat strains by Western blotting
(Fig. 2). The results show clearly that when WKY BMDMs are
primed with LPS and stimulated with ATP, they produce mark-
edly increased levels of active IL-1 (Fig. 2A), IL-18 (Fig. 2B),
and mature caspase-1 (Fig. 2C) when compared with NTN-
resistant LEW BMDMs. As with P2RX7 levels, the ATP-induced
release of IL-1 and IL-18 is partially regulated by Crgn1 and
Crgn2, as WKY.LCrgn1,2 BMDMs showed markedly reduced
active caspase-1 and decreased IL-18 and IL-1 protein levels.
The differential activation of the Nlrp3 inflammasome in WKY
and LEW BMDMs is mainly a result of differences in P2RX7
levels, as the use of the potassium ionophore Nigericin, previ-
ously reported to induce the activation of Nlrp3 [32], did not
result in increased active IL-1 (assessed by Western blot and
sandwich ELISA) and caspase-1 secretion in LPS-primed WKY
rat macrophages (Fig. 2D). Taken together, these results show
that although Crgn1 and Crgn2 do not control the transcrip-
tional regulation of the Nlrp3-inflammasome pathway (Fig.
1A), the maturation of IL-1, IL-18, and caspase-1 is partially
under the genetic regulation of both loci (Fig. 2).
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The increased P2RX7-mediated IL-1 and IL-18
secretion in WKY BMDMs is caspase-1-dependent and
is not a result of an up-regulation of the pro forms of
the cytokines
The differential activation of the P2RX7-Nlrp3-inflammasome
pathway in WKY, LEW, and WKY.LCrgn1,2 BMDMs could be
the result of the priming process, whereby LPS stimulation
leads the enhanced TLR4-dependent NF-B activation in the
WKY rat. To dissect whether the priming (LPS) or the post-
translational caspase-1-dependent maturation (ATP through
P2RX7) accounts for the observed differences in the release of
IL-1 and IL-18, we assessed pro-IL-1 and pro-IL-18 in the
cell lysates (excluding the supernatants) of WKY, LEW, and
WKY.LCrgn1,2 BMDMs (Fig. 3A). The results show that BM-
DMs from all of the rat strains produce similar amounts of
pro-IL-1 and pro-IL-18 in response to LPS and that ATP stim-
ulation does not modify the amount of either cytokine (Fig.
3A). In addition, the increased IL-1 and IL-18 levels are a
result of increased caspase-1 activation in the WKY BMDMs, as































































































































































































































































































Figure 1. The expression of
P2RX7-Nlrp3-inflammasome path-
way genes is genetically controlled
in the macrophages of rats showing
different susceptibility to Crgn.
(A) The expression of the major
transcripts belonging to the
P2RX7-Nlrp3-inflammasome path-
way in the BMDMs of the WKY,
WKY.LCrgn1,2, and LEW rats. All
of the genes were assessed by qRT-
PCR at basal levels, except for
Pycard, for which expression levels
were up-regulated significantly in
LPS (100 ng/ml, 10 h)-stimulated
cells. Hprt, Hypoxanthine guanine
phosphoribosyl transferase. (B)
Schematic and simplified represen-
tation of the P2RX7-Nlrp3-inflam-
masome pathway, highlighting the
color-coded differential expression
between the WKY and LEW
BMDMs. (C) Western blot analysis
of P2RX7 protein levels in basal
(untreated) and LPS (1 g/ml,
5 h)-treated BMDMs from WKY,
LEW, and WKY.LCrgn1,2 rats; n 
6 rats were used for qRT-PCR.
Western blot results are representa-
tive of three independent experi-
ments. *P  0.01, **P  0.001
compared to WKY rats.
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completely the production of the active forms of both cyto-
kines (Fig. 3B).
P2RX7-Nlrp3-inflammasome activation and its genetic
control in Crgn in the rat
We extended our in vitro observations obtained in BMDMs to
the ex vivo analysis of Nlrp3-inflammasome activation in the
nephritic glomeruli of WKY, LEW, and WKY.LCrgn1,2 rats.
Glomeruli were isolated from the renal cortex 4 days after the
NTN induction and were cultured for 48 h in serum-free DMEM
media (to allow macrophage growth). We observed that P2RX7
and active IL-1, IL-18, and caspase-1 were increased markedly in
the nephritic glomeruli of WKY rats when compared with LEW
(Fig. 4). In addition, we showed that the source of the increased
P2RX7-mediated Nlrp3-inflammasome activation within the ne-
phritic glomeruli is the infiltrating CD68 macrophages (Supple-
mental Fig. 3). Interestingly, the WKY.LCrgn1,2 rats, which show
reduced glomerular crescents and macrophage infiltration 10
days following NTN induction [8], also showed reduced P2RX7
(Fig. 4A) and active caspase-1 (Fig. 4B), IL-1 (Fig. 4C), and
IL-18 (Fig. 4D), suggesting that Crgn1 and Crgn2 control P2RX7-
mediated Nlrp3-inflammasome activation in the nephritic glom-
eruli. Immunohistochemical analysis of Nlrp3 and ED-1 on con-
secutive WKY kidney sections 10 days after NTN induction
showed that glomerular Nlrp3 staining is primarily associated
with ED-1 cells (Fig. 4E).
Macrophages are important effector cells in the pathophysi-
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Figure 2. The P2RX7-Nlrp3-inflammasome-mediated IL-1 and IL-18
release is increased markedly in NTN-susceptible WKY rat macro-
phages. BMDMs from WKY, LEW, and WKY.LCrgn1,2 rats were first
primed with LPS (1 g/ml, 5 h) and treated with ATP (5 mM) for
30 min. Cell lysates and supernatants were subjected to Western
blotting for detection of pro and active forms of IL-1 (A), IL-18
(B), and caspase-1 (C). WKY- and LEW-primed BMDMs LPS (1 g/
ml, 5 h) were also treated with Nigericin (10 g/ml) for 30 min,
and cell lysates and supernatants were subjected to Western blot-
ting for active IL-1 and caspase-1 detection. IL-1 levels were also
quantified by sandwich ELISA (D). Western blot results are repre-
sentative of three independent experiments; n  4 rats were used
for IL-1 ELISA.
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glomeruli as early as 2.5 h following the injection of nephro-
toxic serum, and their number increases and peaks at Day 4
[6]. We have previously shown by bone marrow transplanta-
tion experiments that genetically controlled macrophage infil-
tration and activation underpin glomerular injury in this
model [8]. In this study, we focused on one particular proin-
flammatory pathway that partly explains the increased overac-
tivity of WKY macrophages that is linked to susceptibility to
Crgn. We previously conducted a microarray experiment in
basal and LPS-stimulated BMDMs and identified P2RX7 as a
markedly overexpressed transcript in the WKY cells when com-
pared with LEW ones [11]. This led us to hypothesize that the
members of Nlrp3-inflammasome pathway could also be differ-
entially expressed between the NTN-susceptible WKY and
NTN-resistant LEW BMDMs.
In the present study, we found that (1) there is genetic con-
trol of transcription of multiple genes belonging to the Nlrp3-
inflammasome pathway in the WKY and LEW BMDMs and
that this is not under the control of the two previously identi-
fied NTN QTL (Crgn1 and Crgn2); (2) there is genetic con-
trol of P2RX7 protein levels in BMDMs and nephritic glomer-
uli of WKY and LEW rats and that this is partly regulated by
Crgn1 and Crgn2; and (3) caspase-1 activation and the release
of active IL-1 and IL-18 are also under genetic control in
WKY and LEW BMDMs and nephritic glomeruli. Crgn1 and
Crgn2 partly regulate the Nlrp3-inflammasome activation in
vitro and ex vivo. In summary, the P2RX7-Nlrp3-inflam-
masome pathway is genetically regulated, and its activation re-
sults in caspase-1-dependent IL-1 and IL-18 release in pri-
mary macrophages and glomeruli following NTN induction. In
BMDMs, Crgn1 and Crg2 do not control the transcription but
only the post-translational maturation of these cytokines. We
have previously, positionally cloned Crgn1 and Crgn2 genes,
which are Fcgr3 and Jund, respectively. Although we have
shown a role for these genes in FcR-mediated macrophage ac-
tivation, we cannot exclude a potential role for these genes in
P2RX7-mediated inflammasome activation. However, it is note-
worthy that Crgn1 and Crgn2 contain hundreds of expressed
genetic variants and may include genes other than Fcgr3 and
Jund implicated in Nlrp3-inflammasome activation.
The release of ATP by dying cells is a critical danger signal
in tissues during organ damage, and the ensuing activation of
P2RX7 is a key response in the injured organs [33, 34]. There
are several studies that have examined the role of P2RX7 in
renal inflammation and fibrosis [35]. For instance,
P2RX7/ mice exhibit reduced tubular injury, inflamma-
tion, and fibrosis when compared with WT mice following uni-
lateral ureteric obstruction [36]. The proinflammatory role of
P2RX7 in experimental Crgn in mice and rats led to the find-
ing that the increased expression of this receptor in the glom-
eruli coincides with the peak of macrophage infiltration and
IL-1 expression, and its absence or inhibition results in re-
duced glomerular thrombosis and macrophage infiltration [22,
31]. In humans, The P2RX7 gene is highly polymorphic, and
single nucleotide polymorphisms underlie the variation ob-
served in receptor function [37] and more broadly, the associ-
ation with whole-body phenotypes and/or disease [38]. We
have sequenced the protein-coding region of P2RX7 in WKY
and LEW rats and found one synonymous coding variant, as
well as single nucleotide polymorphisms and deletion/inser-
tions in the promoter region. This suggests that the observed
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Figure 3. The increased P2RX7-mediated
IL-1 and IL-18 secretion in WKY BM-
DMs is caspase-1-dependent and is not a
result of an up-regulation of the pro
forms of the cytokines. (A) BMDMs from
WKY, LEW, and WKY.LCrgn1,2 rats were
primed with LPS (1 g/ml, 5 h) and
treated 30 min with ATP (5 mM). To as-
sess cellular levels of the pro forms of
IL-1 and IL-18, cell lysates (not superna-
tants) were subjected to Western blotting.
(B) The use of caspase-1 inhibitor
(yVAD) and the assesement of IL-1 and
IL-18 production in WKY BMDMs when
the Nlrp3 inflammasome was activated
with LPS (1 g/ml, 5 h) followed by
stimulation with ATP (5 mM, 30 min).
These results are representative of three
independent experiments.
132 Journal of Leukocyte Biology Volume 93, January 2013 www.jleukbio.org
be a result of sequence variations within the vicinity of the
gene (cis control) or elsewhere in the genome (trans control).
The results described in the present study suggest that genetic
loci control the expression of P2RX7 in macrophages and that
fine-tuning of its expression levels is crucial for the activation
of the Nlrp3-inflammasome and subsequent release of active
IL-1 and IL-18 associated with susceptibility to Crgn.
Although there are reports implicating inflammasomes in
chronic [39] kidney disease, there is no report showing the
role of inflammasomes in macrophage-dependent Crgn. Our
study is the first describing the P2RX7-Nlrp3-inflammasome
activation in the NTN model in the WKY rat. Our current
study highlights the importance of the Nlrp3-inflammasome
pathway that is triggered by P2RX7 activation and results in
IL-1 and IL-18 release in macrophages. Targeting the Nlrp3-
inflammasome pathway could be considered as a therapeutic
approach in Crgn.
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